Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230111057111N1Phase 2Completed
Phase 2, open-label trial of shikonin in diabetic foot ulcer (DFU) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Local infection, Wound degree and size and 3 more. Started Jan 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230111057111N1.